This is the authors' abstract. We don't add key points for this paper.
In this study, we constructed a layered graphene oxide (GO) nanocomplex with pH-responsive charge-reversible chitosan-aconitic anhydride (CS-Aco), biocompatible polyethylene glycol (PEG) and low molecular weight polyethylenimine (PEI). This was employed as a novel delivery system for intracellular pH-triggered DOX and short hairpin RNA (shRNA) controlled release and synergistic therapy. The nanocomplex GO-PEI-PEG/DOX/CS-Aco/PEI/shRNA exhibited high drug and shRNA loading, and good stability at physiological pH. In an acid pH environment, the negatively charged CS-Aco layer hydrolyzed into positively charged chitosan, causing the shielding layers of the nanocomposite to loosen. The disassembled GO-PEI-PEG/DOX and chitosan efficiently ruptured the endosome, significantly facilitating the release of DOX and PEI/shRNA into the cytoplasm, and then the shRNA disassembled rapidly because of its weak electrostatic interactions with the short PEI chains. Consequently, GO-PEI-PEG/DOX/CS-Aco/PEI/shRNA exhibited excellent shABCG2 and DOX co-delivery efficiency in HepG2 cells, which was better than that of GO/DOX and the non-charge-reversible GO-PEI-PEG/DOX/CS-Car/PEI/shRNA nanocomplex. Furthermore, this novel nanocomplex had high efficiency in silencing ABCG2 expression, and exhibited a significant synergistic efficacy in chemotherapy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
He et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: